Fremont, United States
Ultima Genomics, founded in 2016, is a trailblazing company in the Biotechnology, Health Care, and Life Sciences sectors. Their mission revolves around "unleashing the power of genomics at scale," as they aim to drive advances in biology and human health by scaling genomic information. Situated in the United States, the company challenges conventional sequencing technologies with a revolutionary new architecture designed to significantly lower sequencing costs and expand information scalability.
The company made a notable impact in the investment world with a substantial $600.00M grant received in June 2022. This round was backed by prominent investors such as Founders Fund, D1 Capital Partners, General Atlantic, Khosla Ventures, Andreessen Horowitz / a16z, Playground Global, aMoon, Lightspeed, and Marius Nacht. With these strategic investments, Ultima Genomics is well-positioned to catalyze a new phase in 21st-century genomics, overcoming traditional trade-offs in breadth, depth, and frequency of genomic data usage.
